IRIS
CUDILLO, LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 23.902
EU - Europa 2.623
AS - Asia 2.524
SA - Sud America 331
AF - Africa 33
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 4
Totale 29.423
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 23.811
SG - Singapore 1.096
DE - Germania 654
CN - Cina 594
IT - Italia 344
RU - Federazione Russa 338
UA - Ucraina 335
BR - Brasile 278
IE - Irlanda 226
HK - Hong Kong 224
VN - Vietnam 194
GB - Regno Unito 162
FR - Francia 148
FI - Finlandia 128
KR - Corea 128
SE - Svezia 121
BD - Bangladesh 68
PL - Polonia 56
JP - Giappone 46
IN - India 44
CA - Canada 43
MX - Messico 20
AR - Argentina 19
UZ - Uzbekistan 18
CZ - Repubblica Ceca 17
BE - Belgio 16
ES - Italia 16
NL - Olanda 16
IQ - Iraq 15
CR - Costa Rica 14
ZA - Sudafrica 13
AT - Austria 12
ID - Indonesia 12
KG - Kirghizistan 11
LT - Lituania 10
TR - Turchia 10
IL - Israele 7
PE - Perù 7
PH - Filippine 7
PK - Pakistan 7
AE - Emirati Arabi Uniti 6
CL - Cile 6
EC - Ecuador 6
IR - Iran 6
MA - Marocco 6
SA - Arabia Saudita 5
AU - Australia 4
CO - Colombia 4
EU - Europa 4
JM - Giamaica 4
JO - Giordania 4
PY - Paraguay 4
RO - Romania 4
VE - Venezuela 4
BG - Bulgaria 3
CH - Svizzera 3
DK - Danimarca 3
GR - Grecia 3
MY - Malesia 3
PA - Panama 3
SY - Repubblica araba siriana 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AZ - Azerbaigian 2
DZ - Algeria 2
EG - Egitto 2
ET - Etiopia 2
HU - Ungheria 2
LB - Libano 2
SV - El Salvador 2
TH - Thailandia 2
TN - Tunisia 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
CG - Congo 1
CY - Cipro 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GM - Gambi 1
GY - Guiana 1
HN - Honduras 1
KE - Kenya 1
KW - Kuwait 1
KZ - Kazakistan 1
LV - Lettonia 1
MD - Moldavia 1
NO - Norvegia 1
NP - Nepal 1
PS - Palestinian Territory 1
PT - Portogallo 1
SN - Senegal 1
TG - Togo 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 29.423
Salva come PNG Salva come JPEG
Città #
Woodbridge 6.801
Wilmington 6.107
Houston 5.473
Ann Arbor 638
Singapore 634
Fairfield 589
Ashburn 471
Chandler 435
San Jose 294
Jacksonville 287
Seattle 279
Beijing 227
Hong Kong 222
Dublin 216
Cambridge 212
Medford 165
New York 136
Rome 123
Dearborn 120
Santa Clara 113
Los Angeles 92
The Dalles 79
Lawrence 78
Zhengzhou 78
Helsinki 66
Ho Chi Minh City 56
Council Bluffs 55
Moscow 54
Lauterbourg 51
Hanoi 50
Kraków 41
Buffalo 40
Tokyo 40
Dallas 38
Munich 34
San Diego 34
Menlo Park 30
Mülheim 29
Milan 27
Orem 24
Falls Church 21
São Paulo 20
Redondo Beach 18
Norwalk 17
Shanghai 17
Brno 16
Brussels 16
Chicago 16
Boardman 15
Frankfurt am Main 15
Hefei 15
London 15
Phoenix 15
Bologna 14
Chennai 14
Montreal 14
San José 14
Guangzhou 13
Kunming 13
Warsaw 13
Brooklyn 12
Denver 12
Nanjing 12
San Francisco 12
University Park 12
Da Nang 11
Haiphong 11
Rieti 11
Toronto 11
Johannesburg 10
Mountain View 10
Nuremberg 10
Rio de Janeiro 10
Atlanta 9
Boston 9
Palo Alto 9
Saint Petersburg 9
San Mateo 9
Belo Horizonte 8
Brasília 8
Jakarta 8
Nürnberg 8
Redmond 8
Redwood City 8
Verona 8
Amsterdam 7
Cleveland 7
Nanchang 7
Stockholm 7
Chongqing 6
Columbus 6
Creede 6
Hounslow 6
Lima 6
New Delhi 6
Poplar 6
Wuhan 6
Ankara 5
Auburn Hills 5
Changsha 5
Totale 25.185
Salva come PNG Salva come JPEG
Nome #
Persistent risk of HBV reactivation despite extensive lamivudine prophylaxis in haematopoietic stem cell transplant recipients who are anti-HBc-positive or HBV-negative recipients with an anti-HBc-positive donor 577
Femoral catheters: safety and efficacy in peripheral blood stem cell collection 541
Treatment of acute graft-versus-host disease with prednisolone: significant survival advantage for day+5 responders and no advantage for nonresponders receiving anti-thymocyte globulin 536
Aspergillus niger infection in patients with haematological diseases: a report of eight cases 510
Characterization of coagulase-negative staphylococcal isolates from blood with reduced susceptibility to glycopeptides and therapeutic options 510
Bowel ultrasonography as an aid for diagnosis of intestinal acute graft-versus-host-disease after allogeneic haematopoietic stem cell transplantation 509
Possibility of long-term remission in patients with advanced hematologic malignancies after reduced intensity conditioning regimen (RIC) and allogeneic stem cell transplantation 498
Autologous peripheral blood stem cell transplantation as first line treatment of multiple myeloma: an Italian multicenter study 497
Positive selection of CD34+ cells by immunoadsorption: factors affecting the final yield and hematopoietic recovery in patients with hematological malignancies and solid tumors 491
High incidence of post-transplant cytomegalovirus reactivations in myeloma patients undergoing autologous stem cell transplantation after treatment with bortezomib-based regimens: a survey from the Rome transplant network. 477
Fibrin glue for refractory hemorrhagic cystitis after unrelated marrow, cord blood, and haploidentical hematopoietic stem cell transplantation 465
Femoral catheters: safety and efficacy in peripheral blood stem cell collection 465
Efficacy and safety of human leucocyte interferon-alpha treatment in patients younger than 60 years of age with polycythaemia vera 464
Ceftriaxone plus amikacin in a single daily dose as empiric antibiotic therapy in granulocytopenic patients 462
A fatal case of invasive fungal sinusitis by Scopulariopsis acremonium in a bone marrow transplant recipient 462
3-Tesla MR spectroscopy in patients subjected to bone marrow transplantation: clinical correlations. 456
The policy of the Rome Transplant Network (RTN), a metropolitan (2009). The Potential Application Of The Allogeneic Transplant By The Policy Of Widespread Donor Search: An Intention-To-Treat Analysis From The Rome Transplant Network. 455
Hepatitis B reactivation characterized by HBsAg negativity and anti-HbsAg antibodies persistence in haematopoietic stem cell transplanted patient after lamivudine withdrawal 452
Localization of aspergillosis to the central nervous system among patients with acute leukemia: Report of 14 cases 448
The therapeutic use of cord blood 445
Breakthrough fusariosis in a patient with acute lymphoblastic leukemia receiving voriconazole prophylaxis [6] 440
Sezary syndrome in relapse after reduced intensity allogeneic transplant successfully treated with donor lymphocyte infusion 438
Platelet gel for treatment of mucocutaneous lesions related to graft-versus-host disease after allogeneic hematopoietic stem cell transplant 436
aplastic anemia and viral hepatitis 436
Peripheral polyneuropathy during treatment with alpha-2 interferon 432
Management of carbapenem resistant Klebsiella pneumoniae infections in stem cell transplant recipients: An italian multidisciplinary consensus statement 429
Pre-transplant persistence of minimal residual disease does not contraindicate allogeneic stem cell transplantation for adult patients with acute myeloid leukemia 429
Efficacy of caspofungin as secondary prophylaxis in patients undergoing allogeneic stem cell transplantation with prior pulmonary and/or systemic fungal infection 422
breakthrough fusariosis in a patient with acute lymphoblastic leukemia receiving voriconazole prophylaxis 420
Controversies on antibiotic lock technique duration: experience with a 3-day course for hematological patients 420
The Rome Transplant Network model compared to the Italian Bone Marrow Donor Registry activity for unrelated donor search process and transplant efficiency for hematologic malignancy 420
Outcomes of allogeneic stem cell transplantation for secondary therapy-related acute myeloid leukaemia 419
Results of a multicenter, controlled, randomized clinical trial evaluating the combination of piperacillin/tazobactam and tigecycline in high-risk hematologic patients with cancer with febrile neutropenia. 418
Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation 417
Femoral catheters: safety and efficacy in peripheral blood stem cell collection 416
A prospective study comparing quantitative Cytomegalovirus (CMV) polymerase chain reaction in plasma and pp65 414
Epidemiology of invasive fungal diseases in haematopoietic stem cell transplant recipients: preliminary analysis of a multicentre, prospective, observational study from Italy 412
Aplastica Anemia and Viral Hepatitis 411
Reduced intensity allogeneic transplantation in primary cutaneous t-cell lymphomas. 408
Development of cellulitis caused by Aeromonas hydrophila in allogeneic hematopoietic transplantation: a case report. 404
Total parenteral nutrition enriched with glutamine and ω-3 fatty acid in adult patients undergoing autologous stem cell transplantation. 403
Recombinant factor VIIa for the management of severe hemorrhages in patients with hematologic malignancies 403
Bone marrow processing with a gravity sedimentation technique: experience of 13 cases 401
Extracorporeal photochemotherapy in the treatment of acute and chronic GvHD: experience from Rome Transplant Network 395
Incidence and outcome of invasive fungal diseases after allogeneic stem cell transplantation: a prospective study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO 388
Positive selection of CD34+ cells by immunoadsorption: factors affecting the final yield and hematopoietic recovery in patients with hematological malignancies and solid tumors 387
Platelet gel is highly effective in treating muco-cutaneous lesions related to graft-versus-host disease 382
Molecular remission in advanced acute promyelocytic leukaemia after treatment with the oral synthetic retinoid Tamibarotene 379
Extracorporeal photopheresis as first-line treatment in high-risk graft-versus-host disease 374
Allogeneic hematopoietic stem cell transplantation in Primary Cutaneous T Cell Lymphoma 369
Successful treatment of disseminated fusariosis with high dose liposomal amphotericin-B in a patient with acute lymphoblastic leukemia [4] 365
Quality controls of cord blood units according to JACIE standards are highly predictive in unrelated cord blood transplant 364
Fibrin glue directly applied on damaged bladder mucosa during cystoscopy is highly effective to treat severe, refractory, haemorrhagic cystitis after allogeneic transplant 363
Fibrin glue therapy for severe hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation 360
Reduced-intensity conditioning combined with standard GvHD prophylaxis is tolerable and highly effective for patients with primary cutaneous T-cell lymphomas undergoing allogeneic transplantation in advanced disease stage. 357
Rituximab in post allogeneic hematopoietic stem cell transplantation membranous nephropathy: a case report. 349
Level of minimal residual disease after consolidation therapy predicts outcome in acute myeloid leukemia 343
Il Trapianto di Cellule Stminali Emopoietiche. 333
Unmanipulated bone marrow transplantation from haplo-identical related donor for patients with high-risk haematological malignancies 327
Epidemiological survey on severe infectious diseases 318
Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia after Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey 315
Molecular remission in advanced acute promyelocytic leukaemia after treatment with the oral synthetic retinoid Tamibarotene 311
The potential application of the allogeneic transplant according to a widespread donor search policy: an intention-to-treat analysis from the Rome Transplant Network 295
The Potential Application of the Allogeneic Transplant by the Policy of Widespread Donor Search: an Intention- To-Treat Analysis from the Rome Transplant Network . 294
Gemtuzumab ozogamicin in combination with intensive chemotherapy for relapsed/refractory acute myeloid leukemia 279
Haploidentical, G-CSF-primed, unmanipulated bone marrow transplantation for patients with high-risk hematological malignancies: an update 274
A fatal case of invasive fungal sinusitis by Scopulariopsis acremonium in a bone marrow transplant recipient 209
Procalcitonin is a reliable marker of severe systemic infection in neutropenic haematological patients with mucositis 192
Haploidentical, unmanipulated, G-CSF-primed bone marrow transplantation for patients with high-risk hematologic malignancies 192
MATCHED-PAIR ANALYSIS OF TRANSPLANT FROM HAPLOIDENTICAL, UNMANIPULATED BONE MARROW DONOR VERSUS HLA IDENTICAL SIBLING FOR PATIENTS WITH HEMATOLOGICAL MALIGNANCIES 188
Preliminary results of a counselling programme for fertility preservation in female cancer patients: the experience of the GEMME DORMIENTI network 180
Cerebellar Neurocysticercosis as Long-Term Complication of Allogeneic Haematopoietic Stem Cell Transplantation from Haploidentical Donor 179
High incidence of post-transplant cytomegalovirus reactivations in myeloma patients undergoing autologous stem cell transplantation after treatment with bortezomib-based regimens: a survey from the Rome transplant network 170
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study 169
Sezary syndrome in relapse after reduced intensity allogeneic transplant successfully treated with donor lymphocyte infusion 168
Platelet-rich plasma as treatment for persistent ocular epithelial defects 166
Infections by carbapenem-resistant Klebsiella pneumoniae in SCT recipients: a nationwide retrospective survey from Italy 158
Fibrin glue for refractory hemorrhagic cystitis after unrelated marrow, cord blood, and haploidentical hematopoietic stem cell transplantation 153
Identification of Predictive Factors for Overall Survival and Response during Hypomethylating Treatment in Very Elderly (≥75 Years) Acute Myeloid Leukemia Patients: A Multicenter Real-Life Experience 89
Management of latent tuberculosis infection (LTBI) in adult patients with newly diagnosed acute leukemia: results of a survey among Italian centers belonging to SEIFEM (Sorveglianza Epidemiologica Infezioni nelle Emopatie) group 60
Risk-adapted MRD-directed therapy for young acute myeloid leukemia adults: 6-year update of the GIMEMA AML1310 trial 58
Totale 29.620
Salva come PNG Salva come JPEG
Categoria #
all - tutte 65.338
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.338
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202131 0 0 0 0 0 0 0 0 0 0 0 31
2021/2022787 26 103 43 47 26 72 38 44 47 57 46 238
2022/20231.100 116 105 48 159 74 235 84 60 121 13 62 23
2023/2024397 45 14 19 11 38 123 17 7 11 3 3 106
2024/20251.704 82 424 187 117 32 86 110 105 189 134 115 123
2025/20262.869 209 173 329 284 270 129 362 310 312 291 110 90
Totale 29.620